Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05827614
Title Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy, in Subjects With Tumors With Oncogene Amplifications (POTENTIATE)
Acronym POTENTIATE
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boundless Bio
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.